Laboratoire HRA Pharma;INSERM - Institut National de la Santé et de la Recherche Médicale
发明人:
申请号：
EP13724304.4
公开号：
EP2854817B1
申请日:
2013.05.24
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to the use of ulipristal acetate, or any of its metabolites, in preventing or treating a breast tumor in a patient, preferably a patient that carries a mutation in BRCA1 gene.
